SaNOtize

company

About

SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$24M
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.

SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$24M
SaNOtize has raised a total of $24M in funding over 2 rounds. Their latest funding was raised on Aug 24, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 24, 2022 Series B $24M 2 OurCrowd Detail

Investors

Number of Lead Investors
Number of Investors
1
2
SaNOtize is funded by 2 investors. OurCrowd and Agricultural Bank of China are the most recent investors.
Investor Name Lead Investor Funding Round
OurCrowd Yes Series B
Agricultural Bank of China Series B